⌘K

Login Start Free

Home/Filings/4/0001628280-25-016196

4//SEC Filing

Hoffman Robert E. 4

Accession 0001628280-25-016196

CIK 0001434868other

View on SEC.gov Company Profile

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 4:19 PM ET

Size

18.6 KB

Accession

0001628280-25-016196

Insider Transaction Report

Form 4

Period: 2025-04-01

Esperion Therapeutics, Inc.ESPR

Director

Transactions

Award
Stock Option (right to buy)
2025-04-01+40,000→ 40,000 total
Exercise: $1.41Exp: 2035-04-01→ Common Stock (40,000 underlying)

Footnotes (1)

[F1]The awards vest over a three (3) year period in equal annual installments the first of which will be April 1, 2026.

Documents

2 files

Issuer

Esperion Therapeutics, Inc.

CIK 0001434868

Entity typeother

Related Parties

1

filerCIK 0001166288

Filing Metadata

Form type: 4
Filed: Apr 1, 8:00 PM ET
Accepted: Apr 2, 4:19 PM ET
Size: 18.6 KB

View on SEC.gov